about
Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors.AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors.Nef from SIV(mac239) decreases proliferation and migration of adenoid-cystic carcinoma cells and inhibits angiogenesis.Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT.Ru(η6-arene) complexes of combretastatin-analogous oxazoles with enhanced anti-tumoral impact.Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.Uptake and phototoxicity of meso-tetrahydroxyphenyl chlorine are highly variable in human biliary tract cancer cell lines and correlate with markers of differentiation and proliferation.Differential regulation of connective tissue growth factor in renal cells by histone deacetylase inhibitors.Oxazole-bridged combretastatin A analogues with improved anticancer properties.Labeling and glycosylation of peptides using click chemistry: a general approach to (18)F-glycopeptides as effective imaging probes for positron emission tomography.Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling.Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosis.The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.Conjugates of the fungal cytotoxin illudin M with improved tumour specificity.bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells.Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer.Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell lines.Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori-infection.The combination of tamoxifen and 9cis retinoic acid exerts overadditive anti-tumoral efficacy in rat hepatocellular carcinoma.Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent colorectal cancer cells.Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib.The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma modelsInducibility of microsomal liver function may differentiate cirrhotic patients with maintained compared with severely compromised liver reserve.The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells.Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?The synthetic retinoid adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro.Potentiated anticancer effects on hepatoma cells by the retinoid adapalene.The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells.The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer.Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer-Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy
P50
Q39412021-97CD9212-00DC-4502-91B2-0ECF5F84A8ECQ39444806-1F5472F1-234C-4C78-98D9-FF9D22BEA831Q39505952-84095D25-2702-4846-8F45-B8CB2762E4F6Q39543881-012B6D7A-1A60-4CED-983D-2CA050EFC2EFQ39665091-FBE7C3BC-FD80-4E9F-9AE1-C8E224B17785Q39692519-CB408EFA-9D8E-4F2D-A970-F0015432A61EQ39720222-22F17A29-E329-4CFD-8FD5-F5D2EE442D4DQ39742039-B1D76569-04DD-4793-9638-730D0D624FA2Q39746380-C7CF388D-3413-4A3C-968A-475F51C171D4Q39759909-63A16C9B-8CA1-4366-98F5-1137E012B3BAQ39780536-FF86EBB6-370C-4422-80E5-CEF8DD1989BBQ39832858-980ADAFD-0C71-49D8-96DB-EEC26FBFCAD8Q39913123-CD0D0FF4-E9DD-4AB5-837F-782EEA2AB5E0Q39948905-8869C735-974E-4D13-8C0E-49FB6DDC5717Q40155540-FF12A4FB-3BFA-4ACE-915F-2A938AAA040BQ40385543-8C9DB104-D64C-4CCC-BAE4-C92193797AE4Q40404488-72DB3D04-D701-4837-878C-4514A07C5B14Q40502540-B39CA7A7-AFD5-4E11-9144-3E7A4F798E55Q40552990-59ED28E5-F711-4D37-9FDB-2F64A3BAD367Q41807243-A56A7EF1-5997-4BBA-9ED2-3ECF09533CDFQ41917123-F6A8513F-87AE-4273-9479-79118EAC9B91Q42164554-44060318-9062-432C-9C6C-41AE51FE2FECQ42438693-A08F872D-02DF-4000-843B-D544E3F3B820Q43878365-DBA81027-F73B-4C41-97BB-079DAF1964C8Q44259756-F47E7143-C5CF-4ECC-9C4D-36A8938468C6Q44594539-71EBE341-1EBC-46C5-9E8A-ADC46810DA6DQ44856484-FAEEACA3-F406-4B95-A06A-BE075043A29FQ45309583-4BB7FB76-DA69-45C2-8B0C-FB8B0C722BEFQ46200730-1031BE4A-7B50-4C38-9D1F-DDE3B8B99003Q91963654-82192D9C-F389-47AA-9BA0-8CF6FC520898
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Matthias Ocker
@ast
Matthias Ocker
@ca
Matthias Ocker
@da
Matthias Ocker
@de
Matthias Ocker
@en
Matthias Ocker
@es
Matthias Ocker
@fr
Matthias Ocker
@it
Matthias Ocker
@nl
Matthias Ocker
@pt
type
label
Matthias Ocker
@ast
Matthias Ocker
@ca
Matthias Ocker
@da
Matthias Ocker
@de
Matthias Ocker
@en
Matthias Ocker
@es
Matthias Ocker
@fr
Matthias Ocker
@it
Matthias Ocker
@nl
Matthias Ocker
@pt
prefLabel
Matthias Ocker
@ast
Matthias Ocker
@ca
Matthias Ocker
@da
Matthias Ocker
@de
Matthias Ocker
@en
Matthias Ocker
@es
Matthias Ocker
@fr
Matthias Ocker
@it
Matthias Ocker
@nl
Matthias Ocker
@pt
P214
P245
P106
P108
P1153
6602646310
P21
P214
P245
P31
P496
0000-0001-8263-6288
P735
P7859
viaf-139468480